We are live on
!
Find out more
SM
SG3 Management Portfolio holdings
AUM
$6.45K
1-Year Est. Return
61.81%
This Fund
S&P 500
This Quarter
Est. Return
+9.09%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$4B
AUM Growth
-$1.25B
(-24%)
Cap. Flow
-$1.28B
Cap. Flow
% of AUM
-32.02%
Top 10 Holdings %
Top 10 Hldgs %
20.82%
Holding
1,612
New
626
Increased
195
Reduced
208
Closed
487
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$10.2M |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$6.08M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$5.95M |
| 4 |
Biogen
BIIB
|
+$5.94M |
| 5 |
Aon
AON
|
+$5.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$294M |
| 2 |
Lennar Class A
LEN
|
+$76.3M |
| 3 |
RH
RH
|
+$25.1M |
| 4 |
ARK Genomic Revolution ETF
ARKG
|
+$22.5M |
| 5 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$22.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 1.79% |
| 2 | Communication Services | 1.57% |
| 3 | Technology | 1.13% |
| 4 | Consumer Discretionary | 1.05% |
| 5 | Financials | 0.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
CALL
Jefferies Financial Group
JEF
$12.7B
| $5.12M | 0.13% |
+177,820
| New | +$4.85M |
|
|
SOS
177
CALL
SOS Limited
SOS
$17.3M
| $5.06M | 0.13% |
+1,356
| New | +$5.32M |
|
178
PUT
ServiceNow
NOW
$114B
| $5M | 0.13% |
+50,000
| New | +$5.28M |
|
179
PUT
Rekor Systems
REKR
$84.6M
| $5M | 0.12% |
+250,000
| New | +$3.72M |
|
180
CALL
AvePoint
AVPT
$2.72B
| $4.96M | 0.12% |
+447,200
| New | +$6.26M |
|
181
CALL
DraftKings
DKNG
$11.8B
| $4.89M | 0.12% |
79,800
-38,900
| -33% | -$2.34M |
|
182
PUT
NIO
NIO
$12.1B
| $4.88M | 0.12% |
125,200
-9,500
| -7% | -$484K |
|
183
CALL
Twilio
TWLO
$29B
| $4.84M | 0.12% |
14,200
| – | – |
|
|
SAGE
184
CALL
DELISTED
Sage Therapeutics
SAGE
| $4.83M | 0.12% |
+64,600
| New | +$5.3M |
|
185
CALL
Southern Company
SO
$106B
| $4.82M | 0.12% |
+77,600
| New | +$4.65M |
|
186
PUT
CRISPR Therapeutics
CRSP
$4.77B
| $4.81M | 0.12% |
39,500
+29,500
| +295% | +$4.45M |
|
187
Sunrun
RUN
$2.27B
| $4.78M | 0.12% |
79,000
+9,000
| +13% | +$625K |
|
188
CALL
Direxion Daily Semiconductor Bull 3X ETF
SOXL
$16.7B
| $4.78M | 0.12% |
+125,000
| New | +$4.68M |
|
189
CALL
uniQure
QURE
$2.93B
| $4.72M | 0.12% |
140,000
+85,000
| +155% | +$3.05M |
|
|
ONC
190
CALL
BeOne Medicines Ltd
ONC
$33.4B
| $4.7M | 0.12% |
13,500
| – | – |
|
191
CALL
The Greenbrier Companies
GBX
$1.52B
| $4.69M | 0.12% |
+99,400
| New | +$4.25M |
|
192
CALL
Pinduoduo
PDD
$124B
| $4.69M | 0.12% |
+35,000
| New | +$5.91M |
|
|
SPWR
193
PUT
DELISTED
SunPower Corporation Common Stock
SPWR
| $4.68M | 0.12% |
140,000
| – | – |
|
194
PUT
Qualcomm
QCOM
$160B
| $4.64M | 0.12% |
+35,000
| New | +$5.05M |
|
|
FINV
195
CALL
FinVolution Group
FINV
$1.15B
| $4.63M | 0.12% |
+660,000
| New | +$3.51M |
|
196
CALL
Upland Software
UPLD
$13.6M
| $4.6M | 0.12% |
9,750
-1,150
| -11% | -$555K |
|
197
CALL
Carnival Corporation Ltd
CCL
$38B
| $4.52M | 0.11% |
170,400
-967,000
| -85% | -$22.8M |
|
|
PARA
198
CALL
DELISTED
Paramount Global Class B
PARA
| $4.51M | 0.11% |
100,000
+84,000
| +525% | +$5.13M |
|
199
CALL
Revolve Group
RVLV
$1.82B
| $4.49M | 0.11% |
+100,000
| New | +$4.07M |
|
|
NBIS
200
CALL
Nebius Group N.V.
NBIS
$47.8B
| $4.48M | 0.11% |
+70,000
| New | +$4.68M |
|
Similar funds
EAM
CAM
CCM
GPCM
MAM
BGCI
TPL
RC
SG3 Management's Q1 2021 Portfolio in Review
As of Q1 2021, SG3 Management held 1,612 positions worth $4B, down 24% from $5.25B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
SG3 Management withdrew a net $1.28B in Q1 2021, closing 487 positions and reducing 208 holdings. Its most notable exit was Amazon, an estimated $294M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 1.8% of assets, up from 0.67% a quarter earlier, followed by Communication Services and Technology.
Against the trend, SG3 Management opened a new position in Albemarle worth $4.16M.
- SG3 Management's largest Q1 2021 buy was Albemarle: 28,500 shares worth $4.16M.
- SG3 Management added most to Jazz Pharmaceuticals in Q1 2021, an estimated $10.2M increase.
- SG3 Management's biggest Q1 2021 reduction was RH, cutting an estimated $25.1M.
- SG3 Management fully exited Amazon in Q1 2021, selling an estimated $294M.
- SG3 Management's ten largest holdings make up 21% of its $4B portfolio in Q1 2021.
- SG3 Management opened 626 new positions and closed 487 in Q1 2021.
- SG3 Management's portfolio value fell 24% quarter-over-quarter to $4B.
Based on SG3 Management's 13F filing for Q1 2021, filed 17 May 2021.